Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Cited by (1,003)

Items 301–400 of 1,003

1. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
   Kevin O. Saunders, Norbert Pardi, Robert Parks, Sampa Santra, Zekun Mu, Laura L. Sutherland, Richard M. Scearce, Maggie Barr, Amanda Eaton, Giovanna E. Hernandez et al. · 2021 · npj Vaccines
2. Photocaged 5′ cap analogues for optical control of mRNA translation in cells
   Nils Klöcker, Florian P. Weissenboeck, Melissa van Dülmen, Petr Špaček, Sabine Hüwel, Andrea Rentmeister · 2022 · Nature Chemistry
3. Synthetic modified messenger RNA for therapeutic applications
   Gao, Minsong, Zhang, Qingyi, Feng, Xin-Hua, Liu, Jianzhao · 2021 · Acta Biomaterialia
4. Treatment of Hemophilia A Using Factor VIII Messenger RNA Lipid Nanoparticles
   Chen, Chun-Yu, Tran, Dominic M., Cavedon, Alex, Cai, Xiaohe, Rajendran, Raj, Lyle, Meghan J., Martini, Paolo G.V., Miao, Carol H. · 2020 · Molecular Therapy Nucleic Acids
5. COVID-19 vaccines adverse events: potential molecular mechanisms
   Malamatenia Lamprinou, Athanasios Sachinidis, Εleni Stamoula, Theofanis Vavilis, Georgios Papazisis · 2023 · Immunologic Research
6. Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into Nanoparticles
   Melo, Mariane, Porter, Ely, Zhang, Yuan, Silva, Murillo, Li, Na, Dobosh, Brian, Liguori, Alessia, Skog, Pat, Landais, Elise, Menis, Sergey et al. · 2019 · Molecular Therapy
7. New Kids on the Block: RNA-Based Influenza Virus Vaccines
   Francesco Berlanda Scorza, Norbert Pardi · 2018 · Vaccines
8. A New Era for Rare Genetic Diseases: Messenger RNA Therapy
   Paolo G.V. Martini, Lin T. Guey · 2019 · Human Gene Therapy
9. Nucleic Acid Drugs—Current Status, Issues, and Expectations for Exosomes
   Yoji Yamada · 2021 · Cancers
10. Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency
    McGee, Joshua E., Kirsch, Jack R., Kenney, Devin, Cerbo, Faith, Chavez, Elizabeth C., Shih, Ting-Yu, Douam, Florian, Wong, Wilson W., Grinstaff, Mark W. · 2025 · Nature Biotechnology
11. Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
    Cailin E. Deal, Andrea Carfı́, Obadiah J. Plante · 2021 · Vaccines
12. Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination
    Ai‐Ming Yu, Mei‐Juan Tu · 2021 · Pharmacology & Therapeutics
13. ‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
    Peter I. Parry, Astrid Lefringhausen, Conny Turni, C. Neil, Robyn Cosford, Nicholas James Hudson, Julian Gillespie · 2023 · Biomedicines
14. Recent progress in mRNA cancer vaccines
    Ruhui Yao, Chunyuan Xie, Xiaojun Xia · 2024 · Human Vaccines & Immunotherapeutics
15. mRNA Cancer Vaccines
    Katja Fiedler, Sandra Lazzaro, Johannes Lutz, Susanne Rauch, Regina Heidenreich · 2016 · Recent results in cancer research/Recent Results in Cancer Research
16. siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
    Tutu Kalita, Saba Abbasi Dezfouli, Lalit Mohan Pandey, Hasan Uludağ · 2022 · Pharmaceutics
17. A new developing class of gene delivery: messenger RNA-based therapeutics
    Meng Zhao, Jonathan O’Keeffe Ahern, Jing Lyu, Luca Pierucci, Dezhong Zhou, Wenxin Wang · 2017 · Biomaterials Science
18. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
    Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda et al. · 2021 · Vaccines
19. An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primates
    Manon Ripoll, Marie‐Clotilde Bernard, Céline Vaure, Emilie Bazin, Sylvie Commandeur, Vladimir Perkov, Katia Lemdani, Marie‐Claire Nicolaï, Patrick Bonifassi, Antoine Kichler et al. · 2022 · Biomaterials
20. Eliciting antitumor immunity via therapeutic cancer vaccines
    Kun Peng, Xiaoxue Zhao, Yang‐Xin Fu, Yong Liang · 2025 · Cellular and Molecular Immunology
21. Label-free analysis of mRNA capping efficiency using RNase H probes and LC-MS
    Beverly, Michael, Dell, Amy, Parmar, Parul, Houghton, Leslie · 2016 · Analytical and Bioanalytical Chemistry
22. Small-molecule-based regulation of RNA-delivered circuits in mammalian cells
    Tyler E. Wagner, Jacob R. Becraft, Katie Bodner, Brian P. Teague, Xin Zhang, Amanda Rui En Woo, Ely B. Porter, Bremy Alburquerque, Brian S. Dobosh, Oliwia Andries et al. · 2018 · Nature Chemical Biology
23. Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells
    Rein Verbeke, Ine Lentacker, Karine Breckpot, J. Janssens, Serge Van Calenbergh, Stefaan C. De Smedt, Heleen Dewitte · 2019 · ACS Nano
24. Messenger RNA expressing PfCSP induces functional, protective immune responses against malaria in mice
    Katherine L. Mallory, Justin A. Taylor, Xiaoyan Zou, Ishita N. Waghela, Cosette G. Schneider, Michael Q. Sibilo, Neeraja M. Punde, Leah Perazzo, Tatyana Savransky, Martha Sedegah et al. · 2021 · npj Vaccines
25. Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
    Cole J. Batty, Mark T. Heise, Eric M. Bachelder, Kristy M. Ainslie · 2020 · Advanced Drug Delivery Reviews
26. Stability Modelling of mRNA Vaccine Quality Based on Temperature Monitoring throughout the Distribution Chain
    Zoltán Kis · 2022 · Pharmaceutics
27. Lipid nanoparticle-based mRNA vaccines in cancers: Current advances and future prospects
    Tao Huang, Lushan Peng, Yingying Han, Dan Wang, Xiaoyun He, Junpu Wang, Chunlin Ou · 2022 · Frontiers in Immunology
28. Advanced technologies for the development of infectious disease vaccines
    Akash Gupta, Arnab Rudra, Kaelan Reed, Róbert Langer, Daniel G. Anderson · 2024 · Nature Reviews Drug Discovery
29. Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
    Haque, A. K. M. Ashiqul, Dewerth, Alexander, Antony, Justin S., Riethmüller, Joachim, Schweizer, Georg R., Weinmann, Petra, Latifi, Ngadhnjim, Yasar, Hanzey, Pedemonte, Nicoletta, Sondo, Elvira et al. · 2018 · Scientific Reports
30. mRNA in cancer immunotherapy: beyond a source of antigen
    Lien Van Hoecke, Rein Verbeke, Heleen Dewitte, Ine Lentacker, Karim Y. Vermaelen, Karine Breckpot, Sandra Van Lint · 2021 · Molecular Cancer
31. From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies
    Hironori Adachi, Martin Hengesbach, Yi‐Tao Yu, Pedro Morais · 2021 · Biomedicines
32. Lipid Nanoparticle Delivery Systems to Enable mRNA-Based Therapeutics
    Sean C. Semple, Robert D. Leone, Christopher Barbosa, Ying K. Tam, Paulo J.C. Lin · 2022 · Pharmaceutics
33. Engineering approaches for RNA-based and cell-based osteoarthritis therapies
    Carlisle R. DeJulius, Bonnie L. Walton, Juan Manuel Colazo, Richard d’Arcy, Nora Francini, Jonathan M. Brunger, Craig L. Duvall · 2024 · Nature Reviews Rheumatology
34. mRNA vaccine sequence and structure design and optimization: Advances and challenges
    Lei Jin, Yuanzhe Zhou, Sicheng Zhang, Shi‐Jie Chen · 2024 · Journal of Biological Chemistry
35. mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
    Sittplangkoon, Chutamath, Alameh, Mohamad-Gabriel, Weissman, Drew, Lin, Paulo J. C., Tam, Ying K., Prompetchara, Eakachai, Palaga, Tanapat · 2022 · Frontiers in Immunology
36. Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines
    Iman Mohammed Alfagih, Basmah Nasser Aldosari, Bushra T. AlQuadeib, Alanood S. Almurshedi, Mariyam M. Alfagih · 2020 · Pharmaceutics
37. HIV mRNA Vaccines—Progress and Future Paths
    Zekun Mu, Barton F. Haynes, Derek W. Cain · 2021 · Vaccines
38. Current view on novel vaccine technologies to combat human infectious diseases
    Zrinka Matić, Maja Šantak · 2021 · Applied Microbiology and Biotechnology
39. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo
    Lili Cui, Morag Rose Hunter, Silvia Sonzini, Sara G. T. Pereira, Steven M. Romanelli, Kai Liu, Weimin Li, Lihuan Liang, Bin Yang, Najet Mahmoudi et al. · 2021 · Small
40. Deep generative models design mRNA sequences with enhanced translational capacity and stability
    He Zhang, Hailong Liu, Yushan Xu, Haoran Huang, Yiming Liu, Jia Wang, Yan Qin, Haiyan Wang, Lili Ma, Zhiyuan Xun et al. · 2025 · Science
41. Maximizing the Translational Yield of mRNA Therapeutics by Minimizing 5′-UTRs
    Trepotec, Zeljka, Aneja, Manish K., Geiger, Johannes, Hasenpusch, Guenther, Plank, Christian, Rudolph, Carsten · 2019 · Tissue Engineering Part A
42. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Jonas B. Sandbrink, Robin J. Shattock · 2020 · Frontiers in Immunology
43. mRNA vaccines: the most recent clinical applications of synthetic mRNA
    Suji Kwon, Minseon Kwon, Seongeun Im, Kyuri Lee, Hyukjin Lee · 2022 · Archives of Pharmacal Research
44. Nanoparticle-mediated delivery of anti-PU.1 siRNA via localized intracisternal administration reduces neuroinflammation
    Ralvenius, William T., Andresen, Jason L., Huston, Margaret M., Penney, Jay, Bonner, Julia Maeve, Fenton, Owen S., Langer, Robert, Tsai, Li‐Huei · 2024 · Advanced Materials
45. Advances in the design and development of SARS-CoV-2 vaccines
    Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, Meng-Di Yuan, Xiaohong Zhao, Zibiao Li, Dai‐Xu Wei · 2021 · Military Medical Research
46. Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages
    Hanieh Moradian, Toralf Roch, Larissa Anthofer, Andreas Lendlein, Manfred Gossen · 2022 · Molecular Therapy — Nucleic Acids
47. Self-Amplifying RNA Vaccine Candidates: Alternative Platforms for mRNA Vaccine Development
    Christin Schmidt, Barbara S. Schnierle · 2023 · Pathogens
48. mRNA Cancer Vaccines: Construction and Boosting Strategies
    Xiaoqing Liu, Pei Huang, Rusen Yang, Hongzhang Deng · 2023 · ACS Nano
49. N1-Methylpseudouridine and pseudouridine modifications modulate mRNA decoding during translation
    Jeremy G. Monroe, Daniel E. Eyler, Lili Mitchell, Indrajit Deb, Abigail Bojanowski, Pooja Srinivas, Christine M. Dunham, Bijoyita Roy, Aaron T. Frank, Kristin S. Koutmou · 2024 · Nature Communications
50. Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
    Nathan Singh, Xiaojun Liu, Jessica Hulitt, Shuguang Jiang, Carl H. June, Stephan A. Grupp, David M. Barrett, Yangbing Zhao · 2014 · Cancer Immunology Research
51. Viral and Synthetic RNA Vector Technologies and Applications
    Schott, Juliane W, Morgan, Michael, Galla, Melanie, Schambach, Axel · 2016 · Molecular Therapy
52. Self-Amplifying RNA Approach for Protein Replacement Therapy
    Papukashvili, Dimitri, Rcheulishvili, Nino, Liu, Cong, Ji, Yang, He, Yunjiao, Wang, Peng George · 2022 · International Journal of Molecular Sciences
53. Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery
    Magdalena M. Żak, Lior Zangi · 2021 · Pharmaceutics
54. Nucleic acid therapeutics: Past, present, and future
    Sajid Naeem, Ju Zhang, Yang Zhang, Yu Wang · 2024 · Molecular Therapy — Nucleic Acids
55. Linking vaccine adjuvant mechanisms of action to function
    Elana Ben‐Akiva, Asheley Poole Chapman, Tianyang Mao, Darrell J. Irvine · 2025 · Science Immunology
56. Potential Therapeutic Applications of Rna Cap Analogs
    Marcin Ziemniak, Malwina Strenkowska, Joanna Kowalska, Jacek Jemielity · 2013 · Future Medicinal Chemistry
57. Concise Review: Application of In Vitro Transcribed Messenger RNA for Cellular Engineering and Reprogramming: Progress and Challenges
    Heidrun Steinle, Andreas Behring, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2016 · Stem Cells
58. Unlocking the Therapeutic Applicability of LNP-mRNA: Chemistry, Formulation, and Clinical Strategies
    Xiaonan Huang, Yishan Ma, Guanghui Ma, Yufei Xia · 2024 · Research
59. Long Non-Coding RNA Epigenetics
    Marek Kazimierczyk, Jan Wrzesiński · 2021 · International Journal of Molecular Sciences
60. Efficient delivery of VEGF-A mRNA for promoting diabetic wound healing via ionizable lipid nanoparticles
    Wenhui Zha, Ji Wang, Zongke Guo, Yanhao Zhang, Yang Wang, Shuo Dong, Chao Liu, Hanlei Xing, Xinsong Li · 2022 · International Journal of Pharmaceutics
61. mRNA therapeutics: New vaccination and beyond
    Huanhuan Y. Wei, Liangliang Zheng, Zefeng Wang · 2023 · Fundamental Research
62. Synthetic mRNA cap analogs with a modified triphosphate bridge – synthesis, applications and prospects
    Jacek Jemielity, Joanna Kowalska, Anna M. Rydzik, Edward Darżynkiewicz · 2010 · New Journal of Chemistry
63. The Skin You Are In: Design-of-Experiments Optimization of Lipid Nanoparticle Self-Amplifying RNA Formulations in Human Skin Explants
    Blakney, Anna K., McKay, Paul F., Ibarzo Yus, Bárbara, Hunter, Judith E., Dex, Elizabeth A., Shattock, Robin J. · 2019 · ACS Nano
64. Light‐Activated Control of Translation by Enzymatic Covalent mRNA Labeling
    Dongyang Zhang, Cun Yu Zhou, Kayla N. Busby, Seth C. Alexander, Neal K. Devaraj · 2018 · Angewandte Chemie International Edition
65. Double-stranded RNA reduction by chaotropic agents during in vitro transcription of messenger RNA
    Xijun Piao, Vibha Yadav, Eddie Wang, Wayne Chang, Lanna Tau, Benjamin E. Lindenmuth, Sharon Xuesong Wang · 2022 · Molecular Therapy — Nucleic Acids
66. The mRNA Vaccine Revolution: COVID-19 Has Launched the Future of Vaccinology
    Zhongfeng Ye, Joseph Harmon, Wei Ni, Yamin Li, Douglas Wich, Qiaobing Xu · 2023 · ACS Nano
67. tRNA therapeutics for genetic diseases
    Jeff Coller, Zoya Ignatova · 2023 · Nature Reviews Drug Discovery
68. Pseudouridylation meets next-generation sequencing
    Maryam Zaringhalam, Fotini Nina Papavasiliou · 2016 · Methods
69. mRNA – A game changer in regenerative medicine, cell-based therapy and reprogramming strategies
    Oleksandra Chabanovska, Anne-Marie Galow, Robert David, Heiko Lemcke · 2021 · Advanced Drug Delivery Reviews
70. Translation—A tug of war during viral infection
    Batsheva Rozman, Tal Fisher, Noam Stern‐Ginossar · 2022 · Molecular Cell
71. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
    Britta Vallazza, Sebastian Petri, Marco A. Poleganov, Florian Eberle, Andreas N. Kuhn, Uğur Şahin · 2015 · Wiley Interdisciplinary Reviews - RNA
72. mRNA-based therapeutics–Advances and perspectives
    Olga V. Sergeeva, Victor Koteliansky, Timofei S. Zatsepin · 2016 · Biochemistry (Moscow)
73. Multiple covalent fluorescence labeling of eukaryotic mRNA at the poly(A) tail enhances translation and can be performed in living cells
    Lea Anhäuser, Sabine Hüwel, Thomas Zobel, Andrea Rentmeister · 2019 · Nucleic Acids Research
74. A molecular‐level perspective on the frequency, distribution, and consequences of messenger RNA modifications
    Joshua D. Jones, Jeremy G. Monroe, Kristin S. Koutmou · 2020 · Wiley Interdisciplinary Reviews - RNA
75. In vitro evolution of enhanced RNA replicons for immunotherapy
    Li, Yingzhong, Teague, Brian, Zhang, Yuan, Su, Zhijun, Porter, Ely, Dobosh, Brian, Wagner, Tyler, Irvine, Darrell J., Weiss, Ron · 2019 · Scientific Reports
76. Engineering Antiviral Vaccines
    Xingwu Zhou, Xing Jiang, Moyuan Qu, George E. Aninwene, Vadim Jucaud, James Jaehyun Moon, Zhen Gu, Wujin Sun, Ali Khademhosseini · 2020 · ACS Nano
77. Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines
    Chiara Rinoldi, Seyed Shahrooz Zargarian, Paweł Nakielski, Xiaoran Li, Anna Liguori, Francesca Petronella, Dario Presutti, Qiusheng Wang, Marco Costantini, Luciano De Sio et al. · 2021 · Small Methods
78. In Situ Programming of CAR T Cells
    Neha N. Parayath, Matthias T. Stephan · 2021 · Annual Review of Biomedical Engineering
79. mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles
    Andreas Ouranidis, Theofanis Vavilis, Evdokia Mandala, Christina Davidopoulou, Εleni Stamoula, Catherine K. Markopoulou, Anna Karagianni, Kyriakos Kachrimanis · 2021 · Biomedicines
80. Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors
    Judith Stickdorn, Lara Stein, Danielle Arnold-Schild, Jennifer Hahlbrock, Carolina Medina‐Montano, Joschka Bartneck, Tanja Ziß, Evelyn Montermann, Cinja Kappel, Dominika Hobernik et al. · 2022 · ACS Nano
81. Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy
    Samuele Ferrari, Erika Valeri, Anastasia Conti, Serena Scala, Annamaria Aprile, Raffaella Di Micco, Anna Kajaste‐Rudnitski, Eugenio Montini, Giuliana Ferrari, Alessandro Aiuti et al. · 2023 · Cell stem cell
82. Straight to the point: targeted mRNA-delivery to immune cells for improved vaccine design
    Bruna Clemente, Maxime Denis, Camila Pedroso Silveira, Francesca Schiavetti, Michela Brazzoli, Daniela Stranges · 2023 · Frontiers in Immunology
83. Self-Amplifying RNA: Advantages and Challenges of a Versatile Platform for Vaccine Development
    Thomas Vallet, Marco Vignuzzi · 2025 · Viruses
84. Do Cell-Penetrating Peptides Actually “Penetrate” Cellular Membranes?
    Caroline Palm‐Apergi, Peter Lönn, Steven F. Dowdy · 2012 · Molecular Therapy
85. Messenger RNA (mRNA) nanoparticle tumour vaccination
    Kyle K.L. Phua, Smita K. Nair, Kam W. Leong · 2014 · Nanoscale
86. In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies
    Ami R. Patel, Mamadou A. Bah, David B. Weiner · 2020 · BioDrugs
87. Translation of angiotensin-converting enzyme 2 upon liver-and lung-targeted delivery of optimized chemically modified mRNA
    Schrom, Eva, Huber, Maja, Aneja, Manish, Dohmen, Christian, Emrich, Daniela, Geiger, Johannes, Hasenpusch, Günther, Herrmann-Janson, Annika, Kretzschmann, Verena, Mykhailyk, Olga et al. · 2017 · Molecular Therapy — Nucleic Acids
88. Recent advances in mRNA vaccine delivery
    Lu Tan, Xun Sun · 2018 · Nano Research
89. Immunological barriers to haematopoietic stem cell gene therapy
    Carsten T. Charlesworth, Ian Hsu, Adam C. Wilkinson, Hiromitsu Nakauchi · 2022 · Nature reviews. Immunology
90. mRNA vaccines: The future of prevention of viral infections?
    Piotr Rzymski, Agnieszka Szuster‐Ciesielska, Tomasz Dzieciątkowski, Willis Gwenzi, Andrzej Fal · 2023 · Journal of Medical Virology
91. Treating Cystic Fibrosis with mRNA and CRISPR
    Alejandro Da Silva Sanchez, Kalina Paunovska, Ana Cristian, James E. Dahlman · 2020 · Human Gene Therapy
92. Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?
    Akbar Hasanzadeh, Michael Richard Hamblin, Jafar Kiani, Hamid Noori, Joseph Michael Hardie, Mahdi Karimi, Hadi Shafiee · 2022 · Nano Today
93. Class switch towards spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history
    Petra Kiszel, Pál Botond Sík, János Miklós, Erika Kajdácsi, György Sinkovits, László Cervenak, Zoltán Prohászka · 2023 · Scientific Reports
94. Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids
    Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Igor V. Zhigaltsev, Ying K. Tam, Marco A. Ciufolini, Yuen Yi C. Tam, Pieter R. Cullis · 2018 · Journal of Controlled Release
95. Epitranscriptomic marks: Emerging modulators of RNA virus gene expression
    Rachel Netzband, Cara Theresia Pager · 2019 · Wiley Interdisciplinary Reviews - RNA
96. Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression
    Dominika Strzelecka, Mirosław Śmietański, Pawel J. Sikorski, Marcin Warmiński, Joanna Kowalska, Jacek Jemielity · 2020 · RNA
97. mRNA: A promising platform for cancer immunotherapy
    Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang · 2023 · Advanced Drug Delivery Reviews
98. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions
    Anne-Gaëlle Reinhart, Anja Osterwald, Philippe Ringler, Yael Leiser, Matthias E. Lauer, Rainer E. Martin, Christoph Ullmer, Felix F. Schumacher, Claudia Korn, Michael Keller · 2023 · Molecular Pharmaceutics
99. Codon-optimization in gene therapy: promises, prospects and challenges
    Anastasiia Iu. Paremskaia, Anna A. Kogan, Anastasiia Murashkina, Daria A. Naumova, Anakha Satish, Ivan S. Abramov, Sofya G. Feoktistova, Olga N. Mityaeva, Andrei A. Deviatkin, Pavel Volchkov · 2024 · Frontiers in Bioengineering and Biotechnology
100. Review of machine learning for lipid nanoparticle formulation and process development
     Phillip James Dorsey, Christina L. Lau, Ti‐chiun Chang, Peter C. Doerschuk, Suzanne M. D’Addio · 2024 · Journal of Pharmaceutical Sciences